vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and UDR, Inc. (UDR). Click either name above to swap in a different company.
UDR, Inc. is the larger business by last-quarter revenue ($425.8M vs $359.9M, roughly 1.2× AdvanSix Inc.). UDR, Inc. runs the higher net margin — 44.6% vs -0.8%, a 45.4% gap on every dollar of revenue. On growth, AdvanSix Inc. posted the faster year-over-year revenue change (9.4% vs 0.9%). Over the past eight quarters, AdvanSix Inc.'s revenue compounded faster (3.4% CAGR vs 1.3%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
UDR, Inc. is a leading U.S.-headquartered real estate investment trust specializing in owning, operating, and redeveloping high-quality multifamily residential apartment communities. It operates across major U.S. metropolitan markets, catering to a diverse tenant base including young professionals, families, and middle-to-high income households.
ASIX vs UDR — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $425.8M |
| Net Profit | $-2.8M | $189.8M |
| Gross Margin | 7.6% | — |
| Operating Margin | -0.7% | 54.0% |
| Net Margin | -0.8% | 44.6% |
| Revenue YoY | 9.4% | 0.9% |
| Net Profit YoY | -892.9% | 147.2% |
| EPS (diluted) | $-0.11 | $0.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $425.8M | ||
| Q4 25 | $359.9M | $433.1M | ||
| Q3 25 | $374.5M | $431.9M | ||
| Q2 25 | $410.0M | $425.4M | ||
| Q1 25 | $377.8M | $421.9M | ||
| Q4 24 | $329.1M | $422.7M | ||
| Q3 24 | $398.2M | $420.2M | ||
| Q2 24 | $453.5M | $415.3M |
| Q1 26 | — | $189.8M | ||
| Q4 25 | $-2.8M | $222.9M | ||
| Q3 25 | $-2.6M | $40.4M | ||
| Q2 25 | $31.4M | $37.7M | ||
| Q1 25 | $23.3M | $76.7M | ||
| Q4 24 | $352.0K | $-5.0M | ||
| Q3 24 | $22.3M | $22.6M | ||
| Q2 24 | $38.9M | $28.9M |
| Q1 26 | — | — | ||
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 14.3% | — | ||
| Q1 25 | 14.2% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 17.9% | — |
| Q1 26 | — | 54.0% | ||
| Q4 25 | -0.7% | 64.1% | ||
| Q3 25 | -0.9% | 17.7% | ||
| Q2 25 | 7.7% | 18.2% | ||
| Q1 25 | 7.7% | 29.0% | ||
| Q4 24 | -3.9% | 15.7% | ||
| Q3 24 | 7.5% | 16.6% | ||
| Q2 24 | 11.5% | 16.5% |
| Q1 26 | — | 44.6% | ||
| Q4 25 | -0.8% | 51.5% | ||
| Q3 25 | -0.7% | 9.4% | ||
| Q2 25 | 7.7% | 8.9% | ||
| Q1 25 | 6.2% | 18.2% | ||
| Q4 24 | 0.1% | -220.5% | ||
| Q3 24 | 5.6% | 5.4% | ||
| Q2 24 | 8.6% | 7.0% |
| Q1 26 | — | $0.63 | ||
| Q4 25 | $-0.11 | $0.67 | ||
| Q3 25 | $-0.10 | $0.12 | ||
| Q2 25 | $1.15 | $0.11 | ||
| Q1 25 | $0.86 | $0.23 | ||
| Q4 24 | $0.02 | $-0.01 | ||
| Q3 24 | $0.82 | $0.06 | ||
| Q2 24 | $1.43 | $0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $1.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $3.3B |
| Total Assets | $1.7B | $10.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $1.3M | ||
| Q4 25 | $19.8M | $1.2M | ||
| Q3 25 | $23.7M | $1.2M | ||
| Q2 25 | $18.4M | $1.5M | ||
| Q1 25 | $8.3M | $1.3M | ||
| Q4 24 | $19.6M | $1.3M | ||
| Q3 24 | $17.3M | $2.3M | ||
| Q2 24 | $12.1M | $2.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | $5.8B | ||
| Q3 25 | — | $5.8B | ||
| Q2 25 | — | $5.8B | ||
| Q1 25 | — | $5.8B | ||
| Q4 24 | — | $5.8B | ||
| Q3 24 | — | $5.9B | ||
| Q2 24 | — | $5.8B |
| Q1 26 | — | $3.3B | ||
| Q4 25 | $815.2M | $3.3B | ||
| Q3 25 | $818.2M | $3.3B | ||
| Q2 25 | $823.7M | $3.3B | ||
| Q1 25 | $794.4M | $3.3B | ||
| Q4 24 | $774.6M | $3.4B | ||
| Q3 24 | $766.4M | $3.5B | ||
| Q2 24 | $746.6M | $3.7B |
| Q1 26 | — | $10.3B | ||
| Q4 25 | $1.7B | $10.6B | ||
| Q3 25 | $1.7B | $10.6B | ||
| Q2 25 | $1.6B | $10.6B | ||
| Q1 25 | $1.6B | $10.7B | ||
| Q4 24 | $1.6B | $10.9B | ||
| Q3 24 | $1.5B | $11.1B | ||
| Q2 24 | $1.5B | $11.1B |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.77× | ||
| Q3 25 | — | 1.78× | ||
| Q2 25 | — | 1.74× | ||
| Q1 25 | — | 1.74× | ||
| Q4 24 | — | 1.69× | ||
| Q3 24 | — | 1.67× | ||
| Q2 24 | — | 1.55× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | — |
| Free Cash FlowOCF − Capex | $36.1M | — |
| FCF MarginFCF / Revenue | 10.0% | — |
| Capex IntensityCapex / Revenue | 7.7% | 4.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $63.7M | $902.9M | ||
| Q3 25 | $26.6M | $234.9M | ||
| Q2 25 | $21.1M | $250.3M | ||
| Q1 25 | $11.4M | $156.2M | ||
| Q4 24 | $64.2M | $876.8M | ||
| Q3 24 | $57.3M | $230.3M | ||
| Q2 24 | $50.2M | $238.5M |
| Q1 26 | — | — | ||
| Q4 25 | $36.1M | $650.0M | ||
| Q3 25 | $66.0K | $164.6M | ||
| Q2 25 | $-7.2M | $190.1M | ||
| Q1 25 | $-22.6M | $103.2M | ||
| Q4 24 | $29.8M | $627.0M | ||
| Q3 24 | $26.8M | $161.3M | ||
| Q2 24 | $16.7M | $171.1M |
| Q1 26 | — | — | ||
| Q4 25 | 10.0% | 150.1% | ||
| Q3 25 | 0.0% | 38.1% | ||
| Q2 25 | -1.7% | 44.7% | ||
| Q1 25 | -6.0% | 24.5% | ||
| Q4 24 | 9.1% | 148.3% | ||
| Q3 24 | 6.7% | 38.4% | ||
| Q2 24 | 3.7% | 41.2% |
| Q1 26 | — | 4.9% | ||
| Q4 25 | 7.7% | 58.4% | ||
| Q3 25 | 7.1% | 16.3% | ||
| Q2 25 | 6.9% | 14.2% | ||
| Q1 25 | 9.0% | 12.6% | ||
| Q4 24 | 10.4% | 59.1% | ||
| Q3 24 | 7.7% | 16.4% | ||
| Q2 24 | 7.4% | 16.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.05× | ||
| Q3 25 | — | 5.81× | ||
| Q2 25 | 0.67× | 6.64× | ||
| Q1 25 | 0.49× | 2.04× | ||
| Q4 24 | 182.29× | — | ||
| Q3 24 | 2.57× | 10.19× | ||
| Q2 24 | 1.29× | 8.26× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
UDR
| Rental income | $423.3M | 99% |
| Joint venture management and other fees | $2.5M | 1% |
